Post date August 19, 2022 Experience Tenaya Therapeutics $75 million at-the-market offering The common stock is listed on the Nasdaq Global Select Market
Post date August 9, 2022 Experience RxSight $50 million at-the-market offering The stock is listed on the Nasdaq Global Market
Post date November 12, 2021 Experience Cryoport $403 million notes offering and concurrent $249 million stock offering The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Post date November 4, 2021 Experience Aligos Therapeutics $75 million at-the-market offering The company issued common stock in the SEC-registered at-the-market offering
Post date September 21, 2021 Experience ForgeRock $316 million IPO We advised the underwriters on the IPO and NYSE listing
Post date July 7, 2021 Experience Ingram Micro $7.2 billion acquisition by Platinum Equity We advised Ingram Micro on the transaction
Post date July 6, 2021 Experience Aligos Therapeutics $83.6 million follow-on offering We advised the underwriters on the stock offering
Post date May 4, 2021 Experience Marvell Technology private exchange offers We advised the dealer manager in connection with the private exchange offers
Post date April 12, 2021 Experience Marvell Technology $2 billion senior notes offering We advised the initial purchasers on the unregistered debt offering
Post date March 29, 2021 Experience VIZIO Holding $257.2 million IPO We advised the underwriters on the IPO and NYSE listing